Guest guest Posted March 30, 2011 Report Share Posted March 30, 2011 News 10 new results for hepatitis c 3-Drug Combo May Treat Hepatitis CWebMDBy Salynn Boyles March 30, 2011 -- Two highly anticipated hepatitis C drugs are poised to usher in a new era in the treatment of the viral disease as early as this summer, experts say. The Merck drug boceprevir and Vertex Pharmaceutical's similar drug ...See all stories on this topic » Two drugs may revolutionize treatment of hepatitis CLos Angeles TimesBy H. Maugh II, Los Angeles Times Two experimental drugs promise to transform hepatitis C from a debilitating liver disease into a manageable condition for a majority of patients, researchers said Wednesday. The new drugs work by blocking a key ...See all stories on this topic » 2 hepatitis C treatments point to a cureDetroit Free PressBy PATRICIA ANSTETT The 170000 Americans newly diagnosed each year with hepatitis C soon are expected to have two new drug-treatment options that promise a possible cure from the liver disease. Both Merck & Co. of Whitehouse Station, NJ,. and Vertex ...See all stories on this topic » Drugs to revolutionize hepatitis C treatment?Minneapolis Star TribuneTwo experimental drugs promise to transform hepatitis C from a debilitating liver disease into a manageable condition for a majority of patients, researchers said Wednesday. The drugs work by blocking a key enzyme that the hepatitis C virus needs to ...See all stories on this topic » Achillion achieves top-line results from phase 2 trial for hep C drugProactive Investors USA & CanadaAchillion Pharmaceuticals (NASDAQ:ACHN) announced Wednesday positive results from an ongoing phase 2 trial of ACH-1625, a potential treatment for the hepatitis C virus. The Phase 2a trial, which consisted of 64 patients, tested the antiviral drug in ...See all stories on this topic » Achillion Reports Positive Results For Hepatitis C TreatmentWall Street JournalShares of Achillion Pharmaceuticals Inc. (ACHN) rose 6.4% to $7.50 in recent premarket trading Wednesday after the drug company reported positive results for its experimental treatment of chronic hepatitis C. Top-line results of a phase 2a clinical ...See all stories on this topic » Boceprevir Nets Higher Virologic Response in Hep CDoctors LoungeThe addition of boceprevir to the standard treatment for hepatitis C virus genotype 1 infection appears to result in a higher rate of sustained virologic response both in patients who have never been treated and those who have received prior treatment, ...See all stories on this topic » Helping an alcoholic who won't help herselfBoston GlobeQ. My mom is 50 years old and just told me that she has hepatitis C. I think she has probably had it for quite some time, since my late father also had it. The problem is, Mom is an alcoholic and has no interest in giving up booze. I know all about AA, ...See all stories on this topic » Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b ...istockAnalyst.com (press release)30, 2011 (Business Wire) -- Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C. The PPI-461 phase 1b ...See all stories on this topic » Could HIV-infected organs save lives?EurekAlert (press release)Segev suggests that, in transitioning to a system where HIV-infected donor organs can be transplanted into HIV-infected patients, doctors can call on the lessons and experience of transplanting hepatitis C patients with organs from people with the same ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.